Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [912]
News [3692]
Articles [22]
Editorials [1]
Conferences [136]
elearning [0]
BCMA: A new biomarker for multiple myeloma
Dr James Berenson - Oncotherapeutics, West Hollywood, USA
BCMA: A new biomarker for multiple myeloma ( Dr James Berenson - Oncotherapeutics, West Hollywood, USA )
25 Sep 2019
Cancer control in Africa - Special Issue
Prof Twalib Ngoma - Muhimbili University of Health and Allied Sciences, Dar es...
Cancer control in Africa - Special Issue ( Prof Twalib Ngoma - Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania )
25 Jul 2019
Efficient in vitro screening for drug combinations: The TEVA model
Dr Angel Porgador - Ben-Gurion University of the Negev, Beersheeba, Israel
Efficient in vitro screening for drug combinations: The TEVA model ( Dr Angel Porgador - Ben-Gurion University of the Negev, Beersheeba, Israel )
10 Jul 2019
A precision medicine approach to therapeutic resistance using KEAP1 somatic...
Dr Gerald Batist - McGill University - Segal Cancer Centre, Montreal, Canada
A precision medicine approach to therapeutic resistance using KEAP1 somatic mutations ( Dr Gerald Batist - McGill University - Segal Cancer Centre, Montreal, Canada )
10 Jul 2019
Rewriting the code of life: CRISPR-Cas9 genome editing
Prof Jennifer Doudna - University of Berkeley, Berkeley, USA
Rewriting the code of life: CRISPR-Cas9 genome editing ( Prof Jennifer Doudna - University of Berkeley, Berkeley, USA )
10 Jul 2019
Chemotherapy-free strategies in treating leukaemia
Prof Robin Foa - University of Rome, Rome, Italy
Chemotherapy-free strategies in treating leukaemia ( Prof Robin Foa - University of Rome, Rome, Italy )
20 Jun 2019
ADMIRAL trial results: Gilteritinib versus salvage chemotherapy in patients...
Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA
ADMIRAL trial results: Gilteritinib versus salvage chemotherapy in patients with FLT3-mutated relapsed/refractory AML ( Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA )
20 Jun 2019
Multiple myeloma science from EHA 2019
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
Multiple myeloma science from EHA 2019 ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )
20 Jun 2019
CAR T-cell therapy for treating acute leukaemia
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
CAR T-cell therapy for treating acute leukaemia ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )
20 Jun 2019
Selinexor plus cytarabine and idarubicin in patients with relapsed/refractory...
Prof Walter Fiedler - University of Hamburg, Hamburg, Germany
Selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia ( Prof Walter Fiedler - University of Hamburg, Hamburg, Germany )
20 Jun 2019
ECHELON-1 study 3 year update: Frontline brentuximab vedotin with chemotherapy...
Dr Andrea Gallamini - Centre Antoine Lacassagne, Nice, France
ECHELON-1 study 3 year update: Frontline brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma ( Dr Andrea Gallamini - Centre Antoine Lacassagne, Nice, France )
20 Jun 2019
PET after 2 cycles of ABVD in patients with early-stage favourable Hodgkin...
Michael Fuchs - University Hospital of Cologne, Cologne, Germany
PET after 2 cycles of ABVD in patients with early-stage favourable Hodgkin lymphoma ( Michael Fuchs - University Hospital of Cologne, Cologne, Germany )
20 Jun 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation